Multiple actions of systemic artemin in experimental neuropathy

Nature Medicine

Volumn 9, Issue 11, 2003, Pages 1383-1389

  Gardell, Luis R ^a   Wang, Ruizhong ^a   Ehrenfels, Chris ^b   Ossipov, Michael H ^a   Rossomando, Anthony J ^b   Miller, Stephan ^b   Buckley, Carolyn ^b   Cai, Amber K ^b,c   Tse, Albert ^b   Foley, Susan F ^b   Gong, BangJian ^b   Walus, Lee ^b   Carmillo, Paul ^b   Worley, Dane ^b   Huang, Carol ^b,c   Engber, Thomas ^b   Pepinsky, Blake ^b   Cate, Richard L ^b   Vanderah, Todd W ^a   Lai, Josephine ^a   Sah, Dinah W Y ^b   Porreca, Frank ^a   more..

^a UNIVERSITY OF ARIZONA   (United States)

^b BIOGEN   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; HISTOPATHOLOGY; MOTOR DYSFUNCTION; NERVE INJURY; NEUROCHEMISTRY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY DYSFUNCTION;

ANIMALS; BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; DYNORPHINS; MALE; NERVE TISSUE PROTEINS; PAIN; RATS; SPINAL NERVES;

ANIMALIA;

EID: 0344676390     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm944     Document Type: Article

References (50)

1. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S. & Collins, F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132 (1993).
2. Kotzbauer, P.T. et al. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384, 467-470 (1996).
3. Milbrandt, J. et al. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 20, 245-253 (1998).
4. Masure, S. et al. Enovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variants. Eur. J. Biochem. 266, 892-902 (1999).
5. Rosenblad, C. et al. In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin. Mol. Cell. Neurosci. 15, 199-214 (2000).
6. Worby, C.A. et al. Identification and characterization of GFR-alpha3, a novel coreceptor belonging to the glial cell line-derived neurotrophic receptor family. J. Biol. Chem. 273, 3502-3508 (1998).
7. Treanor, J.J. et al. Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83 (1996).
8. Sanicola, M. et al. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc. Natl. Acad. Sci. USA 94, 6238-6243 (1997).
9. Naveilhan, P. et al. Expression and regulation of GFR-alpha3, a glial cell line-derived neurotrophic factor family receptor. Proc. Natl. Acad. Sci. USA 95, 1295-1300 (1998).
10. Jing, S. et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85, 1113-1124 (1996).
11. Baloh, R.H. et al. GFR-alpha3 is an orphan member of the GDNF/neurturin/persephin receptor family. Proc. Natl. Acad. Sci. USA 95. 5801-5806 (1998).
12. Baloh, R.H. et al. TrnR2. a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron 18, 793-802 (1997).
13. Baloh, R.H. et al. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFR-alpha3-RET receptor complex. Neuron 21, 1291-1302 (1998).
14. Enokido, Y. et al. GFR-alpha-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Curr. Biol. 8, 1019-1022 (1998).
15. Klein, R.D. et al. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387, 717-721 (1997).
16. Widenfalk, J., Tomac, A., Lindqvist, E., Hoffer, B. & Olson, L. GFR-alpha3, a protein related to GFR-alpha1, is expressed in developing peripheral neurons and ensheathing cells. Eur. J. Neurosci. 10, 1508-1517 (1998).
17. Orozco, O.E., Walus, L., Sah, D.W., Pepinsky, R.B. & Sanicola, M. GFR-alpha3 is expressed predominantly in nociceptive sensory neurons. Eur. J. Neurosci. 13, 2177-2182 (2001).
18. Payne, R. Neuropathic pain syndromes, with special reference to causalgia and reflex sympathetic dystrophy. Clin. J. Pain 2, 59-73 (1986).
19. Merskey, H. & Bogduk, N. 2nd edn. (eds. Merskey, H. & Bogduk, N.) Classifications of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms 40-43 (IASP Press, Seattle, 1994).
20. Malan, T.P. et al. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain 86, 185-194 (2000).
21. Gardell, L.R. et al. Increased evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J. Neurosci. 23, 8370-8379 (2003)
22. Lai, J. et al. Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain 95, 143-152 (2002).
23. Bennett, D.L. et al. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J. Neurosci. 18, 3059-3072 (1998).
24. Bennett, D.L. et al. The glial cell line-derived neurotrophic factor family receptor components are differentially regulated within sensory neurons after nerve injury. J. Neurosci. 20, 427-437 (2000).
25. Molliver, D.C., Radeke, M.J., Feinstein, S.C. & Snider, W.D. Presence or absence of TrkA protein distinguishes subsets of small sensory neurons with unique cytochemical characteristics and dorsal horn projections. J. Comp. Neurol. 361, 404-416 (1995).
26. Ossipov, M.H. et al. Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. J. Neurosci. 22, 9858-9867 (2002).
27. Acheson, A. & Lindsay, R.M. Non target-derived roles of the neurotrophins. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351, 417-422 (1996).
28. Nichols, M.L. et al. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 286, 1558-1561 (1999).
29. Porreca, F. et al. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc. Natl. Acad. Sci. USA 96, 7640-7644 (1999).
30. Burgess, S.E. et al. Time-dependent descending facilitation from the rostral ventro-medial medulla maintains, but does not initiate, neuropathic pain. J. Neurosci. 22, 5129-5136 (2002).
31. Wang, Z. et al. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J. Neurosci. 21, 1779-1786 (2001).
32. Suzuki, R., Morcuende, S., Webber, M., Hunt, S.P. & Dickenson, A.H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat. Neurosci. 5, 1319-1326 (2002).
33. Porreca, F., Ossipov, M.H. & Gebhart, G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25, 319-325 (2002).
34. Ossipov, M.H., Lai, J., Malan, T.P., Jr., Vanderah, T.W. & Porreca, F. Tonic descending facilitation as a mechanism of neuropathic pain. in Neuropatic Pain: Pathophysiology and Treatment (eds. Hansson, P.T., Fields, H.L., Hill, R.G. & Marchettini, P.) 107-124 (IASP Press, Seattle, 2001).
35. Devor, M. & Seltzer, Z. Pathophysiology of damaged nerves in relation to chronic pain. in Textbook of Pain (eds. Wall, P.D. & Melzack, R.) 129-164 (Churchill Livingstone, London, 1999).
36. Liu, X., Eschenfelder, S., Blenk, K.H., Janig, W. & Habler, H. Spontaneous activity of axotomized afferent neurons after L5 spinal nerve injury in rats. Pain 84, 309-318 (2000).
37. Vollmer, K.O., von Hodenberg, A. & Kolle, E.U. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittelforschung 36, 830-839 (1986).
38. Boucher, T.J. et al. Potent analgesic effects of GDNF in neuropathic pain states. Science 290, 124-127 (2000).
39. Wu, G. et al. Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J. Neurosci. 21, RC140 (2001).
40. McQuay, H.J. et al. Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesia 47, 757-767 (1992).
41. Portenoy, R.K., Foley, K.M. & Inturrisi, C.E. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43, 273-286 (1990).
42. Rowbotham, M.C., Reisner-Keller, L.A. & Fields, H.L. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 41, 1024-1028 (1991).
43. Rose, M.A. & Kam, P.C. Gabapentin: pharmacology and its use in pain management. Anaesthesia 57, 451-462 (2002).
44. Trupp, M., Raynoschek, C., Belluardo, N. & Ibanez, C.F. Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase. Mol. Cell. Neurosci. 11, 47-63 (1998).
45. Kim, S.H. & Chung, J.M An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355-363 (1992).
46. Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M. & Yaksh, T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55-63 (1994).
47. Chen, J.J., Barber, L.A., Dymshitz J. & Vasko, M.R. Peptidase inhibitors improve recovery of substance P and calcitonin gene-related peptide release from rat spinal cord slices. Peptides 17, 31-37 (1996).
48. Gardell, L.R. et al. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J. Neurosci. 22, 6747-6755 (2002).
49. Ehrenfels, C.W., Carmillo, P.J., Orozco, O., Cate, R.L. & Sanicola, M. Perturbation of RET signaling in the embryonic kidney. Dev. Genet. 24, 263-272 (1999).
50. Guo, A., Vulchanova, L., Wang, J., Li, X. & Elde, R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB-4 binding sites. Eur. J. Neurosci. 11, 946-958 (1999).